Stock Comparison
ABBV vs AZN
AbbVie Inc and AstraZeneca PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$242.97B
P/E (TTM)
70.3
23.5
Forward P/E
17.7
15.3
Price/Sales
6.8
4.0
Price/Book
51.1
4.8
EV/EBITDA
25.8
13.2
Dividend Yield
2.03%
2.73%
Profitability
Net Margin
9.82%
17.19%
Operating Margin
29.77%
23.69%
Return on Equity
62.30%
22.00%
Return on Assets
10.50%
8.02%
Growth (YoY)
Revenue Growth
10.20%
6.40%
Earnings Growth
290.40%
2.50%
Price & Risk
Beta
0.3
0.2
52-Week High
$263.65
$208.45
52-Week Low
$197.38
$144.05
Analyst Target
$274.36
$213.69
Compare ABBV and AZN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.